Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL

BITES and CARS and checkpoints, oh my! Updates regarding immunotherapy for myeloid malignancies from the 2018 annual ASH meeting

(2020) Amanda C. Przespolewski et al.   BLOOD REVIEWS

The humanized DRAGA mouse (HLA-A2. HLA-DR4. RAG1 KO. IL-2R g c KO. NOD) establishes inducible and transmissible models for influenza type A infections

(2020) Mirian Mendoza et al.   Human Vaccines & Immunotherapeutics

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

(2020) Anita D'Souza et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The FLAMSA concept—past and future

(2020) Hans-Jochem Kolb et al.   ANNALS OF HEMATOLOGY

Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2020) M. Heuser et al.   ANNALS OF ONCOLOGY

Innovations, challenges, and minimal information for standardization of humanized mice

(2020) Renata Stripecke et al.   EMBO Molecular Medicine

Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV

(2020) Sebastian J. Theobald et al.   PLoS Pathogens

Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy

(2020) Bhagirathbhai Dholaria et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives

(2020) Caterina Lapenta et al.   Vaccines

Role of IFNγ in immune-mediated graft failure occurring after allogeneic hematopoietic stem cell transplantation.

(2019) Pietro Merli et al.   HAEMATOLOGICA

Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats

(2019) Brent A. Williams et al.   Journal of Clinical Medicine

Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation

(2019) Julia K. Bialek-Waldmann et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CAR T cell immunotherapy for human cancer

(2018) Carl H. June et al.   SCIENCE

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens

(2018) Giulia Escobar et al.   Nature Communications

Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation

(2018) Xiaodong Mo et al.   Frontiers of Medicine

Measurable residual disease (MRD) monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

(2018) Felicitas Thol et al.   BLOOD

Multidimensional Analysis Integrating Human T-Cell Signatures in Lymphatic Tissues with Sex of Humanized Mice for Prediction of Responses after Dendritic Cell Immunization

(2017) Valery Volk et al.   Frontiers in Immunology

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

(2016) Hartmut Döhner et al.   BLOOD

Assessment of Minimal Residual Disease in Standard-Risk AML

(2016) Adam Ivey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice

(2015) Y. Najima et al.   BLOOD

Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma

(2015) B S Sundarasetty et al.   GENE THERAPY

Analysis of the functional WT1-specific T-cell repertoire in healthy donors reveals a discrepancy between CD4+and CD8+memory formation

(2015) Sabine Schmied et al.   IMMUNOLOGY

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation

(2015) Bala Sai Sundarasetty et al.   Journal of Translational Medicine

Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies

(2015) Antonio Di Stasi et al.   Frontiers in Immunology

Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV

(2015) Anusara Daenthanasanmak et al.   Molecular Therapy-Methods & Clinical Development

All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase

(2014) Tobias Maetzig et al.   BIOMATERIALS

Dendritic Cell-Mediated Immune Humanization of Mice: Implications for Allogeneic and Xenogeneic Stem Cell Transplantation

(2014) G. Salguero et al.   JOURNAL OF IMMUNOLOGY

Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia

(2013) Mareike Rickmann et al.   ANNALS OF HEMATOLOGY

Lentivirus-Induced Dendritic Cells for Immunization Against High-Risk WT1+ Acute Myeloid Leukemia

(2013) Bala Sai Sundarasetty et al.   HUMAN GENE THERAPY

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo

(2012) Anusara Daenthanasanmak et al.   VACCINE

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

(2010) V. F. Van Tendeloo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY